Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 1;27(5):253-262.
doi: 10.1097/NRL.0000000000000390.

Cerebral Venous Sinus Thrombosis Associated With Coronavirus Disease 2019: Case Report and Review of the Literature

Affiliations
Review

Cerebral Venous Sinus Thrombosis Associated With Coronavirus Disease 2019: Case Report and Review of the Literature

Kessarin Panichpisal et al. Neurologist. .

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is associated with significant risk of acute thrombosis. We present a case report of a patient with cerebral venous sinus thrombosis (CVST) associated with COVID-19 and performed a literature review of CVST associated with COVID-19 cases.

Case report: A 38-year-old woman was admitted with severe headache and acute altered mental status a week after confirmed diagnosis of COVID-19. Magnetic resonance imaging brain showed diffuse venous sinus thrombosis involving the superficial and deep veins, and diffuse edema of bilateral thalami, basal ganglia and hippocampi because of venous infarction. Her neurological exam improved with anticoagulation (AC) and was subsequently discharged home. We identified 43 patients presenting with CVST associated with COVID-19 infection. 56% were male with mean age of 51.8±18.2 years old. The mean time of CVST diagnosis was 15.6±23.7 days after onset of COVID-19 symptoms. Most patients (87%) had thrombosis of multiple dural sinuses and parenchymal changes (79%). Almost 40% had deep cerebral venous system thrombosis. Laboratory findings revealed elevated mean D-dimer level (7.14/mL±12.23 mg/L) and mean fibrinogen level (4.71±1.93 g/L). Less than half of patients had prior thrombotic risk factors. Seventeen patients (52%) had good outcomes (mRS <=2). The mortality rate was 39% (13 patients).

Conclusion: CVST should be in the differential diagnosis when patients present with acute neurological symptoms in this COVID pandemic. The mortality rate of CVST associated with COVID-19 can be very high, therefore, early diagnosis and prompt treatment are crucial to the outcomes of these patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Axial (A) and Sagittal (B) noncontrast computed tomography of brain showing bilateral thalamic and basal ganglia hypodensities and hyperdense straight sinus, vein of Galen and internal cerebral veins.
FIGURE 2
FIGURE 2
(A) Axial T2 FLAIR magnetic resonance imaging showing edema in bilateral thalami and basal ganglia (likely from venous congestion) and bilateral periventricular white matter (likely from hydrocephalus). (B) Axial DWI showing ischemia related to venous congestion in bilateral thalami and basal ganglia. (C) Axial T2 fat saturated showing hydrocephalus and associated transependymal cerebrospinal fluid flow. (D) Axial SWI showing thrombus in internal cerebral veins and their branches. (E) Axial 3D T1 postcontrast showing right transverse/sigmoid thrombus. (F) Sagittal 3D T1 postcontrast showing straight sinus/vein of Galen thrombus. DWI indicates diffusion weighted image; FLAIR, fluid-attenuated inversion recovery; SWI, susceptibility wighted image.
FIGURE 3
FIGURE 3
Axial (A) and Sagittal (B) noncontrast computed tomography of brain 4 weeks after presentation showing normalization of the bilateral thalamic and basal ganglia edema and resolution of the hyperdense dural venous sinus thrombosis.

References

    1. Worldometers.info. 2021. Coronavirus Update (Live): 105,870,383 cases and 2,306,868 deaths from COVID-19 virus pandemic—Worldometer. 2021. Available at: https://www.worldometers.info/coronavirus/. Accessed February 5, 2021.
    1. Nopp S, Moik F, Jilma B, et al. . Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4:1178–1191. - PMC - PubMed
    1. Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020;95:e1060–e1070. - PMC - PubMed
    1. Favas TT, Dev P, Chaurasia RN, et al. . Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41:3437–3470. - PMC - PubMed
    1. Baudar C, Duprez T, Kassab A, et al. . COVID-19 as triggering co-factor for cortical cerebral venous thrombosis? J Neuroradiol. 2021;48:65–67. - PMC - PubMed